Safety and Efficacy of Trastuzumab Emtansine in Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: a Meta-analysis

Advanced or metastatic breast cancer is an incurable disease with high mortality rate worldwide and about 20% of breast cancers overexpress and amplify the human epidermal growth factor receptor 2 (HER2). Achievements in targeted therapy have benefited people during the past decades. Trastuzumab emt...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Kai, Ma, Xuelei, Zhu, Chenjing, Wu, Xin, Jia, Hongyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793192/
https://www.ncbi.nlm.nih.gov/pubmed/26979925
http://dx.doi.org/10.1038/srep23262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793192/
https://www.ncbi.nlm.nih.gov/pubmed/26979925
http://dx.doi.org/10.1038/srep23262

Ejemplares similares